Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study.

导出 LinkOut

翻译打印收藏纠错

作者： Nobuhiro,Tsukada ^[1] ; Momoko,Nishikori ^[2] ; Hiroaki,Goto ^[3] ; Rie,Kanamori ^[4] ; Satoshi,Nishina ^[5] ; Takashi,Seto ^[5] ; Shinsuke,Iida ^[6]

作者单位： Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan. ^[1] Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. ^[2] Division of Hematology/Oncology, Kanagawa Children's Medical Center, Kanagawa, Japan. ^[3] Sanofi Genzyme Medical, Oncology Medical, Sanofi K.K., Tokyo, Japan. ^[4] Medical Affairs, Post-Authorization Regulatory Studies, Sanofi K.K., Tokyo, Japan. ^[5] Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan. iida@med.nagoya-cu.ac.jp. ^[6]

DOI 10.1007/s40801-021-00276-1

PMID 34455570

发布时间 2022-02-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Drugs - real world outcomes

2022年9卷1期

63-78页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study.

Drugs - real world outcomes

相似文献

Drugs - real world outcomes

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study.

Drugs - real world outcomes

相似文献

Drugs - real world outcomes

相关期刊

检索历史清除